Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Erdafitinib in Metastatic Steroid-cell Tumor of the Ovary, NOS

NCT06328491 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT06328491
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06328491 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Erdafitinib in Metastatic Steroid-cell Tumor of the Ovary, NOS
Lead sponsor
University Health Network, Toronto
Phase
Not applicable
Overall status
Completed
Start date
May 30, 2022
Completion date
August 22, 2022
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer, steroid cell tumor, malignant